sec filing
NASDAQ · AVXL
Anavex Life Sciences Corp.
Healthcare · Biotechnology
$2.36
Up+$0.05 (+2.12%)
Updated Sep 17, 2026, 9:57 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 367.21M
- P/E ratio
- -7.28
- Dividend yield
- 0.00%
- 52-week range
- $2.26 – $10.38
- Volume
- 906.1K
- Avg. volume
- 2.3M
Price performance
AVXL price history
1M range · 20 trading sessions · Daily adjusted prices
AVXL closed at $2.36 after 20 trading sessions, down 30.38% for the selected period.
- Last close
- $2.36
- Period change
- -30.38%
- Period low
- $2.36
- Period high
- $3.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $2.44 | $2.4699 | $2.31 | $2.36 | 906.1K |
| Sep 15, 2026 | $2.59 | $2.59 | $2.43 | $2.44 | 946.24K |
| Sep 14, 2026 | $2.61 | $2.64 | $2.55 | $2.60 | 658.13K |
| Sep 11, 2026 | $2.71 | $2.7373 | $2.61 | $2.62 | 624.49K |
| Sep 10, 2026 | $2.71 | $2.735 | $2.615 | $2.66 | 433.77K |
| Sep 9, 2026 | $2.84 | $2.895 | $2.74 | $2.75 | 438.58K |
| Sep 8, 2026 | $2.81 | $2.88 | $2.77 | $2.85 | 559.14K |
| Sep 4, 2026 | $2.82 | $2.905 | $2.81 | $2.86 | 307.15K |
| Sep 3, 2026 | $2.90 | $2.9399 | $2.82 | $2.85 | 421.92K |
| Sep 2, 2026 | $2.88 | $2.9784 | $2.815 | $2.89 | 587.45K |
| Sep 1, 2026 | $2.79 | $2.90 | $2.755 | $2.87 | 826.68K |
| Aug 31, 2026 | $2.95 | $2.97 | $2.78 | $2.80 | 1.03M |
| Aug 28, 2026 | $3.12 | $3.13 | $2.96 | $2.99 | 893.45K |
| Aug 27, 2026 | $3.248 | $3.26 | $3.12 | $3.13 | 652.7K |
| Aug 26, 2026 | $3.50 | $3.54 | $3.22 | $3.24 | 1.18M |
| Aug 25, 2026 | $3.37 | $3.6802 | $3.3651 | $3.56 | 2.48M |
| Aug 24, 2026 | $3.22 | $3.225 | $3.09 | $3.11 | 457.4K |
| Aug 21, 2026 | $3.17 | $3.29 | $3.16 | $3.24 | 480.79K |
| Aug 20, 2026 | $3.34 | $3.36 | $3.09 | $3.13 | 557.18K |
| Aug 19, 2026 | $3.20 | $3.41 | $3.20 | $3.39 | 655.29K |
Latest AVXL news
The latest Smart Investors Daily articles mentioning AVXL.
Stock researchMarket Activity · Short Interest
Loading stock research…